84
Participants
Start Date
November 1, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
December 31, 2027
Vapotherm high velocity therapy (HVT) 2.0 (Vapotherm, Inc, Exeter, NH)
Oxygen therapy will be given via the Vapotherm high velocity therapy (HVT) 2.0 (Vapotherm, Inc, Exeter, NH) using a small-bore cannula, with a flow rate of up to 45 L/min, starting temperature of 37oC and FiO2 of up to 1.0.
Respironics Vision V60
Ventilation will be performed with the Respironics Vision V60 (Philips Healthcare, Murrysville, PA) using an oronasal mask of appropriate size, with FiO2 (up to 1.0), inspiratory (IPAP 12 to 20 cmH2O) and expiratory (EPAP 5 to 10 cm H2O) pressures titrated to alleviate patient's respiratory distress.
Vapotherm, Inc.
INDUSTRY
National University Hospital, Singapore
OTHER